dr. apolo on the safety of nivolumab plus cabozantinib in urothelial carcinoma
Published 7 years ago • 206 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
0:55
dr. apolo on the combination of cabozantinib plus nivolumab in urothelial carcinoma
-
2:09
dr. apolo on cabozantinib plus nivolumab and ipilimumab in urothelial carcinoma
-
0:49
dr. apolo on side effects of cabozantinib plus immunotherapy agents in bladder cancer
-
0:56
dr. apolo on immunotherapy combinations with cabozantinib in genitourinary tumors
-
0:57
exploring cabozantinib with nivolumab and ipilimumab in urothelial carcinoma
-
1:09
dr. apolo on updated javelin results of avelumab in urothelial carcinoma
-
0:51
dr. pal on the safety profile of cabozantinib/atezolizumab in advanced rcc
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer
-
0:55
dr. apolo on avelumab for metastatic urothelial carcinoma
-
1:00
dr. apolo on toxicity challenges with checkpoint inhibitors in bladder cancer
-
1:01
dr. andrea apolo on treatment challenges in metastatic bladder cancer
-
1:03
dr. sklar on the role of nivolumab in bladder cancer
-
1:32
dr. apolo on managing toxicities of checkpoint inhibitors in bladder cancer
-
0:37
dr. petrylak on fda approval of nivolumab in bladder cancer
-
0:54
dr. o’donnell on challenges with pd-l1 testing in bladder cancer
-
1:47
dr. sonpavde on the safety profile of erdafitinib in bladder cancer
-
0:51
dr. pal on the rationale for adding cabozantinib to atezolizumab in prostate cancer
-
0:43
dr. andrea apolo on avelumab in metastatic bladder cancer
-
2:43
cabozantinib after checkpoint inhibitors demonstrates preliminary efficacy in advanced rcc